Close Window

Digital Look Email A Friend

Vitamin D antibodies drive first-half growth at Bioventix

Published by Josh White on 29th March 2019

(Sharecast News) - Monoclonal antibodies developer and supplier Bioventix reported a 24% improvement in its normalised revenue in its half-year report on Friday, to £4.4m.

URL: http://www.digitallook.com/dl/news/story/28831610/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.